These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1693 related items for PubMed ID: 19300221

  • 1. The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-up to a randomized clinical trial.
    Magill SS, Swoboda SM, Shields CE, Colantuoni EA, Fothergill AW, Merz WG, Lipsett PA, Hendrix CW.
    Ann Surg; 2009 Apr; 249(4):657-65. PubMed ID: 19300221
    [Abstract] [Full Text] [Related]

  • 2. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
    Leroy O, Gangneux JP, Montravers P, Mira JP, Gouin F, Sollet JP, Carlet J, Reynes J, Rosenheim M, Regnier B, Lortholary O, AmarCand Study Group.
    Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476
    [Abstract] [Full Text] [Related]

  • 3. Early prediction of Candida glabrata fungemia in nonneutropenic critically ill patients.
    Cohen Y, Karoubi P, Adrie C, Gauzit R, Marsepoil T, Zarka D, Clec'h C.
    Crit Care Med; 2010 Mar; 38(3):826-30. PubMed ID: 20042858
    [Abstract] [Full Text] [Related]

  • 4. The association between anatomic site of Candida colonization, invasive candidiasis, and mortality in critically ill surgical patients.
    Magill SS, Swoboda SM, Johnson EA, Merz WG, Pelz RK, Lipsett PA, Hendrix CW.
    Diagn Microbiol Infect Dis; 2006 Aug; 55(4):293-301. PubMed ID: 16698215
    [Abstract] [Full Text] [Related]

  • 5. Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia.
    Shorr AF, Lazarus DR, Sherner JH, Jackson WL, Morrel M, Fraser VJ, Kollef MH.
    Crit Care Med; 2007 Apr; 35(4):1077-83. PubMed ID: 17312565
    [Abstract] [Full Text] [Related]

  • 6. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
    Safdar A, van Rhee F, Henslee-Downey JP, Singhal S, Mehta J.
    Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
    [Abstract] [Full Text] [Related]

  • 7. Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome.
    Tumbarello M, Sanguinetti M, Trecarichi EM, La Sorda M, Rossi M, de Carolis E, de Gaetano Donati K, Fadda G, Cauda R, Posteraro B.
    J Antimicrob Chemother; 2008 Dec; 62(6):1379-85. PubMed ID: 18782778
    [Abstract] [Full Text] [Related]

  • 8. Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients.
    Piarroux R, Grenouillet F, Balvay P, Tran V, Blasco G, Millon L, Boillot A.
    Crit Care Med; 2004 Dec; 32(12):2443-9. PubMed ID: 15599149
    [Abstract] [Full Text] [Related]

  • 9. Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp.
    Playford EG, Marriott D, Nguyen Q, Chen S, Ellis D, Slavin M, Sorrell TC.
    Crit Care Med; 2008 Jul; 36(7):2034-9. PubMed ID: 18552700
    [Abstract] [Full Text] [Related]

  • 10. Candida glabrata fungaemia in intensive care units.
    Ruan SY, Lee LN, Jerng JS, Yu CJ, Hsueh PR.
    Clin Microbiol Infect; 2008 Feb; 14(2):136-40. PubMed ID: 18042196
    [Abstract] [Full Text] [Related]

  • 11. Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome.
    Dimopoulos G, Ntziora F, Rachiotis G, Armaganidis A, Falagas ME.
    Anesth Analg; 2008 Feb; 106(2):523-9, table of contents. PubMed ID: 18227310
    [Abstract] [Full Text] [Related]

  • 12. Incidence of candidaemia and relationship with fluconazole use in an intensive care unit.
    Bassetti M, Ansaldi F, Nicolini L, Malfatto E, Molinari MP, Mussap M, Rebesco B, Bobbio Pallavicini F, Icardi G, Viscoli C.
    J Antimicrob Chemother; 2009 Sep; 64(3):625-9. PubMed ID: 19622536
    [Abstract] [Full Text] [Related]

  • 13. Candida glabrata fungemia: experience in a tertiary care center.
    Malani A, Hmoud J, Chiu L, Carver PL, Bielaczyc A, Kauffman CA.
    Clin Infect Dis; 2005 Oct 01; 41(7):975-81. PubMed ID: 16142662
    [Abstract] [Full Text] [Related]

  • 14. Candidosis in the intensive care unit: a 20-year survey.
    Tortorano AM, Caspani L, Rigoni AL, Biraghi E, Sicignano A, Viviani MA.
    J Hosp Infect; 2004 May 01; 57(1):8-13. PubMed ID: 15142710
    [Abstract] [Full Text] [Related]

  • 15. Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species.
    Healy CM, Campbell JR, Zaccaria E, Baker CJ.
    Pediatrics; 2008 Apr 01; 121(4):703-10. PubMed ID: 18381534
    [Abstract] [Full Text] [Related]

  • 16. The pattern of fungal infections in critically ill surgical patients.
    Cornwell EE, Belzberg H, offne TV, Dougherty WR, Morales IR, Asensio J, Demetriades D.
    Am Surg; 1995 Oct 01; 61(10):847-50. PubMed ID: 7668455
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of antifungals in the surgical intensive care unit: a multi-institutional study.
    Garey KW, Neuhauser MM, Bearden DT, Cannon JP, Lewis RE, Gentry LO, Kontoyiannis DP.
    Mycoses; 2006 May 01; 49(3):226-31. PubMed ID: 16681815
    [Abstract] [Full Text] [Related]

  • 18. Candidemia: the impact of antifungal prophylaxis in a surgical intensive care unit.
    Swoboda SM, Merz WG, Lipsetta PA.
    Surg Infect (Larchmt); 2003 May 01; 4(4):345-54. PubMed ID: 15012861
    [Abstract] [Full Text] [Related]

  • 19. Epidemiological trends in nosocomial candidemia in intensive care.
    Bassetti M, Righi E, Costa A, Fasce R, Molinari MP, Rosso R, Pallavicini FB, Viscoli C.
    BMC Infect Dis; 2006 Feb 10; 6():21. PubMed ID: 16472387
    [Abstract] [Full Text] [Related]

  • 20. Initial treatment and outcome of Candida glabrata versus Candida albicans bloodstream infection.
    Klevay MJ, Horn DL, Neofytos D, Pfaller MA, Diekema DJ, PATH Alliance.
    Diagn Microbiol Infect Dis; 2009 Jun 10; 64(2):152-7. PubMed ID: 19376667
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 85.